Healthtech Startups

ImageMover offers software that captures photos of COVID-19 test kit results and links them to the test subject along with demographic data, then stores the images in health system archives, EHRs, or regional and work-related databases. The tool is aimed at health systems needing documented records of rapid test results.

2 investors

Imagine Pediatrics develops personalized, integrated care models for children with special health care needs, focusing on improving patient outcomes through value-based care approaches.

2 investors

Immersive Labz builds immersive medical education solutions, including Cadaviz, a virtual human dissection platform that enables learners to visualize and study detailed 3D anatomical models for gross anatomy, radiology, histology, and clinical applications. The company serves medical institutions, educators, and healthcare learners globally seeking to modernize anatomy and clinical education.

2 investors

ImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.

2 investors

Immuneel Therapeutics develops and manufactures cell-based immunotherapies, including CAR-T therapies, for cancer patients, with in-house cGMP lentiviral vector manufacturing. The company aims to make next-generation cell therapies affordable and accessible in India, with a global outlook.

2 investors

Immuneoncia develops immuno-oncology cancer therapeutics, including antibody drugs targeting PD-L1 and CD47, with a program targeting both CD47 and PD-L1 simultaneously. Based in South Korea, the company works to advance immune-based cancer treatments.

2 investors

A nonprofit organization that uses machine learning to accelerate vaccine development. The project applies AI techniques to immunology research and vaccine design.

2 investors

Immunocore is a biotechnology company developing T cell receptor (TCR) based immunomodulating therapies for patients with cancer, infectious diseases, and autoimmune diseases.

2 investors

Immunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer. It also acquires targeted oncology assets and advances them through manufacturing and clinical development.

2 investors

Impactica builds API-first infrastructure and a platform that helps organizations improve access to public benefits such as healthcare, food, and housing by automating the enrollment process. It serves managed care organizations, public and nonprofit benefits enrollment agencies, and financial services organizations in the US.

2 investors

Imprivata is a digital identity company that supports community outreach and corporate social responsibility initiatives through its employee-founded Imprivata Cares organization. The company organizes donation drives, hands-on volunteer projects, and mentoring partnerships focused on local communities.

2 investors

ImYoo develops a platform that enables continuous, scalable biological data collection from patients outside traditional clinical settings to support precision medicine research and drug development. The platform addresses data gaps in healthcare by gathering longitudinal biological measurements from diverse patient populations to improve diagnostics, treatment matching, and clinical trial outcomes.

2 investors

In The Bowl Animal Health (ITBAH) develops and commercializes antiparasitics and therapeutics for pets by incorporating the drug directly into the pet's daily food to improve compliance and convenience. The company serves pet owners and veterinarians in the animal health market.

2 investors

Inaedis develops RTAD (Room Temperature Ambient Drying), a biopharmaceutical formulation platform that enables alternative drug delivery routes for monoclonal antibodies and biologics, including subcutaneous, inhaled, and intranasal administration. The platform reduces manufacturing risk and cost for pharmaceutical companies while improving patient access through room-temperature stability and simplified administration.

2 investors

Inari Medical develops mechanical thrombectomy devices for treating venous thromboembolism conditions, including pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula thrombosis. Its product portfolio includes the FlowTriever and ClotTriever systems, catheters, and blood return systems used by clinicians treating vascular blood clots.

2 investors

Inception Fertility operates a network of fertility brands spanning the fertility life cycle in North America, including fertility centers, donor egg and sperm banks, treatment financing, tissue storage, a virtual pharmacy, and supplements. It serves fertility patients and intended parents, focusing on patient experience and technology-supported care.

2 investors

Indomo Tx develops drug delivery technology focused on dermatology and consumer health, aiming to improve patient outcomes by helping individuals manage their own health. It is backed by a team with expertise in drug delivery, dermatology, and clinical and pharmaceutical fields.

2 investors

Infinity Bio provides immune system analysis through its proprietary MIPSA antibody reactome profiling platform, which identifies the targets of individual immune responses against human viruses, human proteins (autoimmunity), and allergen proteins. The technology, developed at Johns Hopkins University's Laboratory of Precision Immunology, is used for immunology and diagnostics research.

2 investors

Invosys provides Maestro Suite, agent guidance and patient interaction management software for healthcare contact centers. The platform offers a single agent interface, low-code scripted workflows, next-best-action prompts, integrations with patient management and booking systems, and analytics to help agents handle patient calls, emails, and SMS.

2 investors

Inflammatix develops host-response-based molecular diagnostics tests to identify acute infections and sepsis in emergency and critical care settings. The company's diagnostic platform serves healthcare providers treating acutely ill patients, with applications extending to emerging infectious diseases, autoimmune conditions, and transplant rejection.

2 investors

Inflow is an app-based program providing personalized coaching, strategies, and tools to help people with ADHD manage their condition. The platform combines clinical guidance from psychology experts with a supportive community, designed to make mental health support affordable and accessible for neurodiverse individuals.

2 investors

InfoMC develops a cloud-based care management and utilization platform for health plans, managed organizations, and specialty populations to coordinate integrated behavioral and physical health services. The company serves managed behavioral health organizations, Medicare Advantage plans, Medicaid plans, and Employee Assistance Programs.

2 investors

InformAI develops AI-guided clinical solutions for oncology and diagnostic imaging to improve patient treatment outcomes. The company specializes in radiation oncology dose prediction, with their RadOncAI platform designed to optimize head and neck radiation therapy planning while reducing exposure to healthy tissues.

2 investors

Infusion for Health operates infusion therapy centers staffed by clinicians and administrators. The company provides outpatient infusion services in a healthcare setting.

2 investors